Skip to main content

Irenic Capital Management LP

Position in JANX — Janux Therapeutics, Inc.

CIK 1929389 NEW YORK, NY

Position in JANX

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$10,644,675
New position
Shares Held
765,804
first reported quarter
Ownership
1.25%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Irenic Capital Management LP holds $51,691,288 across 2 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in JANX

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-03-31 $10,644,675 765,804